{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:36Z","timestamp":1762899936107,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11102-020-01048-w","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:03:27Z","timestamp":1589616207000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metabolic syndrome and its components in adult hypopituitary patients"],"prefix":"10.1007","volume":"23","author":[{"given":"Simone Yae","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila Souza","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Fernanda Battistuzzi","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Maria Perera","family":"Biondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora","family":"Takito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri Kuhnen","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Galvani Vianna","family":"Amarilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Zampier","family":"Ulbrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:3888\u20133921","journal-title":"J Clin Endocrinol Metab"},{"issue":"10058","key":"1048_CR2","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","volume":"388","author":"CE Higham","year":"2016","unstructured":"Higham CE, Johannsson G, Shalet SM (2016) Hypopituitarism. Lancet 388(10058):2403\u20132415","journal-title":"Lancet"},{"key":"1048_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","volume":"55","author":"M Regal","year":"2001","unstructured":"Regal M, P\u00e1ramo C, Sierra JM, Garci-Mayor RV (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:735\u2013740","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1048_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-013-0127-4","volume":"47","author":"F Tanriverdi","year":"2014","unstructured":"Tanriverdi F, Dokmetas HS, Kebapci N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T (2014) Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database. Endocrine 47:198\u2013205","journal-title":"Endocrine"},{"key":"1048_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000485997","volume":"49","author":"D Milji\u0107","year":"2018","unstructured":"Milji\u0107 D, Popovic V (2018) Metabolic syndrome in hypopituitarism. Front Horm Res 49:1\u201319","journal-title":"Front Horm Res"},{"issue":"8710","key":"1048_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710):285\u2013288","journal-title":"Lancet"},{"key":"1048_CR7","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1210\/jc.2014-3787","volume":"100","author":"JM Pappachan","year":"2015","unstructured":"Pappachan JM, Raskauskiene D, Kutty VR, Clayton RN (2015) Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab 100:1405\u20131411","journal-title":"J Clin Endocrinol Metab"},{"key":"1048_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","volume":"56","author":"S Jasim","year":"2017","unstructured":"Jasim S, Alahdab F, Ahmed AT, Tamhane S, Prokop LJ, Nippoldt TB, Murad MH (2017) Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine 56:33\u201342","journal-title":"Endocrine"},{"key":"1048_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM (2010) Mortality in patients with pituitary disease. Endocr Rev 31:301\u2013342","journal-title":"Endocr Rev"},{"key":"1048_CR10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cen.13141","volume":"85","author":"MW O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly MW, Reulen RC, Gupta S, Thompson CA, Dineen R, Goulden EL, Bugg G, Pearce H, Toogood AA, Gittoes NJ, Mitchell R, Thompson CJ, Ayuk J (2016) ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres. Clin Endocrinol (Oxf) 85:748\u2013756","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1048_CR11","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961","journal-title":"J Clin Endocrinol Metab"},{"key":"1048_CR12","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1210\/jc.2013-1610","volume":"98","author":"M Klose","year":"2013","unstructured":"Klose M, Marina D, Hartoft-Nielsen ML, Klefter O, Gavan V, Hilsted L, Rasmussen AK, Feldt-Rasmussen U (2013) Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. J Clin Endocrinol Metab 98:3802\u20133810","journal-title":"J Clin Endocrinol Metab"},{"key":"1048_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1210\/jc.2013-2394","volume":"99","author":"C Gazzaruso","year":"2014","unstructured":"Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A (2014) Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH: an update. J Clin Endocrinol Metab 99:18\u201329","journal-title":"J Clin Endocrinol Metab"},{"issue":"5 Suppl","key":"1048_CR14","first-page":"41","volume":"22","author":"G Johannsson","year":"1999","unstructured":"Johannsson G, Bengtsson BA (1999) Growth hormone and the metabolic syndrome. J Endocrinol Invest 22(5 Suppl):41\u201346","journal-title":"J Endocrinol Invest"},{"key":"1048_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1530\/EJE-11-0599","volume":"165","author":"J Verhelst","year":"2011","unstructured":"Verhelst J, Mattsson AF, Luger A, Thunander M, G\u00f3th MI, Koltowska-H\u00e4ggstr\u00f6m M, Abs R (2011) Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol 165:881\u2013889","journal-title":"Eur J Endocrinol"},{"key":"1048_CR16","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"key":"1048_CR17","unstructured":"https:\/\/www.idf.org\/e-library\/consensus-statements\/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html . Accessed 14 Feb 2020"},{"key":"1048_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1210\/jc.2009-1326","volume":"95","author":"AF Attanasio","year":"2010","unstructured":"Attanasio AF, Mo D, Erfurth EM, Tan M, Ho KY, Kleinberg D, Zimmermann AG, Chanson P, International Hypopituitary Control Complications Study Advisory Board (2010) Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab 95:74\u201381","journal-title":"J Clin Endocrinol Metab"},{"key":"1048_CR19","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1186\/1471-2458-13-1198","volume":"13","author":"F de Carvalho Vidigal","year":"2013","unstructured":"de Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvad\u00f3 J (2013) Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health 13:1198","journal-title":"BMC Public Health"},{"key":"1048_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11102-016-0747-9","volume":"19","author":"AR Khang","year":"2016","unstructured":"Khang AR, Ku EJ, Kim YA, Roh E, Bae JH, Oh TJ, Kim SW, Shin CS, Kim SY, Kim JH (2016) Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group. Pituitary 19:573\u2013581","journal-title":"Pituitary"},{"key":"1048_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1210\/jc.2012-2940","volume":"98","author":"KMJA Claessen","year":"2013","unstructured":"Claessen KMJA, Appelman-Dijkstra NM, Adoptie DMMM, Roelfsema F, Smit JWA, Biermasz NR, Pereira AM (2013) Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy. J Clin Endocrinol Metab 98:352\u2013361","journal-title":"J Clin Endocrinol Metab"},{"key":"1048_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1530\/EJE-06-0699","volume":"156","author":"AA van der Klaauw","year":"2007","unstructured":"van der Klaauw AA, Biermasz NR, Feskens EJ, Bos MB, Smit JW, Roelfsema F, Corssmit EP, Pijl H, Romijn JA, Pereira AM (2007) The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol 156:455\u2013462","journal-title":"Eur J Endocrinol"},{"issue":"9254","key":"1048_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425\u2013431","journal-title":"Lancet"},{"key":"1048_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2016.84","volume":"12","author":"JA Romijn","year":"2016","unstructured":"Romijn JA (2016) The chronic syndromes after previous treatment of pituitary tumours. Nat Rev Endocrinol 12:547\u2013556","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1048_CR25","doi-asserted-by":"publisher","first-page":"e90602","DOI":"10.1371\/journal.pone.0090602","volume":"9","author":"SD Joustra","year":"2014","unstructured":"Joustra SD, Claessen KMJA, Dekkers OM, Van Beek AP, Wolffenbuttel BHR, Pereira AM, Biermasz NR (2014) High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenoma. PLoS ONE 9(3):e90602","journal-title":"PLoS ONE"},{"key":"1048_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11102-014-0575-8","volume":"18","author":"MA Bhat","year":"2015","unstructured":"Bhat MA, Laway BA, Shah ZA, Wani AI, Mubarik I (2015) Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan\u2019s syndrome on standard replacement therapy: a case control study. Pituitary 18:312\u2013318","journal-title":"Pituitary"},{"key":"1048_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-17-0387","volume":"178","author":"M Wijnen","year":"2018","unstructured":"Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJ (2018) C.M.M. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. Eur J Endocrinol 178:11\u201322","journal-title":"Eur J Endocrinol"},{"key":"1048_CR28","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EJE-18-0306","volume":"179","author":"JOL J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen JOL, Juul A, Therapy of Endocrine Disease (2018) Growth hormone replacement therapy in adults: 30 years of personal clinical experience. Eur J Endocrinol 179:R47\u2013R56","journal-title":"Eur J Endocrinol"},{"key":"1048_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/EC-18-0096","volume":"7","author":"J Verhelst","year":"2018","unstructured":"Verhelst J, Mattsson AF, Camacho-H\u00fcbner C, Luger A, Abs R (2018) The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis. Endocr Connect 7:653\u2013662","journal-title":"Endocr Connect"},{"key":"1048_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MAJ.0b013e3181a84bde","volume":"338","author":"EA Nyenwe","year":"2009","unstructured":"Nyenwe EA, Williamson-Baddorf S, Waters B, Wan JY, Solomon SS (2009) Nonalcoholic Fatty liver disease and metabolic syndrome in hypopituitary patients. Am J Med Sci 338:190\u2013195","journal-title":"Am J Med Sci"},{"key":"1048_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.diabres.2004.05.006","volume":"67","author":"WY Lee","year":"2005","unstructured":"Lee WY, Jung CH, Park JS, Rhee EJ, Kim SW (2005) Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes. Res Clin Pract 67:70\u201377","journal-title":"Res Clin Pract"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01048-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01048-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01048-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T23:50:52Z","timestamp":1621122652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01048-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01048-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2020,5,16]]},"assertion":[{"value":"16 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflcit of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}